Search PubMed⌕ Search

Biomedical subjects

A L Coates

Publications and source records attributed to A L Coates.

94 records · Page 6Linked to original sources
PubMedDate not supplied

Trapped gas and airflow limitation in children with cystic fibrosis and asthma.

Trapped gas (TG) has been shown to be present in cystic fibrosis (CF) and asthma, but its relationship with airflow limitation (AL) has not been explored. TG was defined as the difference between the functional residual capacity measured by body plethysmography [FRC(BP)] and that measured by helium dilution [FRC(He)] expressed as a percentage of total lung capacity (TLC). We studied 21 children with CF and 15 with asthma who had a similar degree of AL and hyperinflation, however the children with CF had greater amounts of TG compared with asthma [15% +/- 2 (mean +/- 1 SE) vs 8 +/- 2, P less than 0.05]. Mixing efficiency (ME), an index of the distribution of ventilation, was found to be lower in the CF children than in those with asthma (34 +/- 4 vs 54 +/- 4). In CF, TG correlated with forced expiratory flow between 25 and 75% of vital capacity (FEF25-75), ME, RV/TLC, and maximal expiratory flow rates at 25 and 50% of vital capacity (Vmax25 and 50, respectively; r = -0.66, -0.61, 0.72, -0.71, -0.74). ME also correlated with the above measures. In asthma, TG did not correlate with the FEF25-75, ME, RV/TLC, Vmax25, or Vmax50. Furthermore, TG was frequently found in patients with asthma with moderate AL while it was often absent in patients with severe AL. For both CF and asthma, neither the severity of AL nor the magnitude of the TG could be predicted from the increase in Vmax50 with helium (delta V50).(ABSTRACT TRUNCATED AT 250 WORDS)

Adolescent↗
PubMedDate not supplied

Multiple factors limit exercise capacity in cystic fibrosis.

Exercise testing was performed in 50 patients with cystic fibrosis to determine whether hemodynamic factors limit exercise capacity in the disease. Prior to exercise testing, lung function and blood gas values were measured. Nutritional status was determined by calculating a weight for height (Wt for Ht) ratio for each subject. A progressive exercise test was used to determine maximum work capacity (Wmax). Cardiac output (Q) (indirect Fick method), and stroke volume (SV) were computed during steady-state exercise at 50% Wmax in 21 of 50 patients. Wmax, SV, Q, and lung function results are expressed as per cent predicted. The mean (+/- SD) Wmax was 75 +/- 23%. Multiple regression analysis showed that maximum voluntary ventilation, resting PaO2, and Wt for Ht accounted for 84% of the variance in Wmax. Although some patients had a reduced SV (mean = 96%) during steady-state exercise, all patients achieved a normal cardiac output (mean = 115%). SV correlated with resting PaO2 but not with lung function. We conclude that exercise capacity in cystic fibrosis is influenced by lung function, nutritional status, and resting hypoxemia, but not by cardiac function; the SV limitation noted in some patients may be due to increased pulmonary vascular resistance related to hypoxemia.

Adolescent↗
PubMedDate not supplied

Effect of dead volume on the efficiency and the cost to deliver medications in cystic fibrosis with four disposable nebulizers.

OBJECTIVES: To evaluate the factors that affect nebulizer efficiency and to compare the relative cost effectiveness of nebulized medications used in the treatment of cystic fibrosis (CF), delivered by four types of disposable jet nebulizers that are widely used in hospitals. DESIGN: The Hudson 1730 Updraft II, Baxter Misty-Neb, Marquest Whisper Jet (WJ), and Marquest Acorn II were evaluated in terms of respirable aerosol output (particles 5 microm or less), nebulizer dead (residual) volume (VD), and time for complete nebulization using saline, salbutamol and tobramycin at flows of 6 and 8 L/min. The respirable fraction (RF) was determined by laser diffraction, and drug output was calculated from the initial volume and concentration of the drug in the nebulizer minus the product of final drug concentration and the VD following nebulization. COST ANALYSIS: The expected pulmonary deposition (DE) was estimated, and incorporated with the material and labour costs to determine the cost effectiveness of each type of nebulizer. RESULTS: With a DE greater than two times that of the WJ at a cost of 2.4 times less, the Updraft II proved most efficient and cost effective of all the nebulizers evaluated in this study. CONCLUSIONS: The cost effectiveness of each nebulizer was determined by its efficiency, which in turn was predominantly related to its VD and RF at each flow. The efficiencies of these four devices were different and could not have been predicted from specifications provided by the respective manufacturers.

Administration, Inhalation↗